ESC 365 - Professor Bertram Pitt

Speaker illustration

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)

Bertram Pitt was born on April 27th 1932 in New York . He received a BA degree from Cornell University in 1953 and his MD from the University of Basel in 1959 . He trained in cardiology at the Johns Hopkins University School of Medicine and remained there until 1977 when he went to the University of Michigan as professor of medicine and director of the division of cardiology, where he is currently professor emeritus . He has received lifetime achievement awards from ESC HF and HFSA as well as the James B Herrick award from the AHA. He has been principal or co-principal investigator of a number of clinical trials including SOLVD, ELITE 1&2 , RALES,EPHESUS, EMPHASIS- HF, TOPCAT, FIGARO and Block-CKD . He has published over 750 peer reviewed articles. He is married to Elaine Pitt MD, a psychiatrist, and has 3 children one of whom Geoffrey Pitt MD is director of cardiovascular research at Weil Cornell Medical College.

Sessions Presentations Articles

Guidelines in Daily Practice I: Potassium binders

Event: Heart Failure 2019

Topic: Cardiovascular Pharmacotherapy

Session type: Guidelines in Practice

Diabetes and heart failure

Event: Heart Failure 2019

Topic: Cardiac Biology and Physiology

Session type: Symposium

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors therapy

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session type: Satellite Symposium - Experts on the Spot

Late Breaking Trials III: Innovative and device therapies

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Special Session

Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Satellite Symposium

Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Satellite Symposium - Experts on the Spot

Furosemide 2.0 - Subcutaneous administration of a novel formulation

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute Heart Failure

Session type: Satellite Symposium - Experts on the Spot

Getting the patient ready for discharge

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute Heart Failure

Session type: Symposium

Furosemide 2.0 - Subcutaneous administration of a novel formulation

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute Heart Failure

Session type: Satellite Symposium

Hyperkalaemia: are your patients missing out?

Event: HEART FAILURE 2016

Topic: Chronic heart failure

Session type: Satellite Symposium

ESC 365 is supported by